Pyridine Moiety: An Insight into Recent Advances in the Treatment of Cancer

Area of Science:

• Medicinal Chemistry
• Drug Discovery
• Oncology

Background:

• Cancer incidence is rising globally, necessitating novel therapeutic strategies.
• Pyridine derivatives are vital pharmacophores with broad therapeutic applications in drug discovery.
• Existing pyridine-based compounds show promise in inhibiting various cancer targets.

Purpose of the Study:

• To review the recent therapeutic advancements of pyridine derivatives in cancer treatment.
• To highlight molecular docking and structure-activity relationship (SAR) studies of pyridine-based anticancer agents.
• To summarize patented and published research on pyridine derivatives for cancer therapy.

Main Methods:

• Literature review of recent scientific publications and patents.
• Analysis of molecular docking studies for pyridine derivatives.
• Examination of structure-activity relationships (SAR) of pyridine-based anticancer compounds.

Main Results:

• Pyridine derivatives demonstrate significant potential as anticancer agents by targeting multiple receptors.
• Molecular docking and SAR studies provide insights into optimizing drug efficacy.
• Recent research indicates a growing focus on novel pyridine derivatives for cancer treatment.

Conclusions:

• Pyridine derivatives represent a promising scaffold for developing next-generation anticancer drugs.
• Further research into molecular interactions and SAR can accelerate the discovery of effective antitumor agents.
• This review provides a comprehensive resource for scientists developing pyridine-based cancer therapeutics.